ONCOTHERAPY SCIENCE, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30 JPY | 0.00% |
|
+36.36% | +30.43% |
| 04-29 | Poland's Tusk calls prosecutor over potential Orlen scandal | RE |
| 04-22 | OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Bio Therapeutic Drugs | 0.00% | +36.36% | +30.43% | -16.67% | -73.21% | 45.75M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4564 Stock
- Charts OncoTherapy Science, Inc.
- Comparison Chart
